174 related articles for article (PubMed ID: 10189270)
1. Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.
Sharma A; Ebling WF; Jusko WJ
J Pharm Sci; 1998 Dec; 87(12):1577-84. PubMed ID: 10189270
[TBL] [Abstract][Full Text] [Related]
2. Mathematical assessment of properties of precursor-dependent indirect pharmacodynamic response models.
Hazra A; Krzyzanski W; Jusko WJ
J Pharmacokinet Pharmacodyn; 2006 Dec; 33(6):683-717. PubMed ID: 17053985
[TBL] [Abstract][Full Text] [Related]
3. Characterization of four basic models of indirect pharmacodynamic responses.
Sharma A; Jusko WJ
J Pharmacokinet Biopharm; 1996 Dec; 24(6):611-35. PubMed ID: 9300353
[TBL] [Abstract][Full Text] [Related]
4. Integrated functions for four basic models of indirect pharmacodynamic response.
Krzyzanski W; Jusko WJ
J Pharm Sci; 1998 Jan; 87(1):67-72. PubMed ID: 9452970
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pharmacodynamic recession slopes for direct and indirect response models.
Krzyzanski W; Jusko WJ
J Pharmacokinet Biopharm; 1998 Aug; 26(4):409-36. PubMed ID: 10214560
[TBL] [Abstract][Full Text] [Related]
6. Mathematical formalism for the properties of four basic models of indirect pharmacodynamic responses.
Krzyzanski W; Jusko WJ
J Pharmacokinet Biopharm; 1997 Feb; 25(1):107-23. PubMed ID: 9353696
[TBL] [Abstract][Full Text] [Related]
7. Mathematical formalism and characteristics of four basic models of indirect pharmacodynamic responses for drug infusions.
Krzyzanski W; Jusko WJ
J Pharmacokinet Biopharm; 1998 Aug; 26(4):385-408. PubMed ID: 10214559
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and concentration-effect analysis of intravenous RGD891, a platelet GPIIb/IIIa antagonist, using mixed-effects modeling (NONMEM).
Zannikos PN; Rohatagi S; Jensen BK; DePhillips SL; Rhodes GR
J Clin Pharmacol; 2000 Oct; 40(10):1129-40. PubMed ID: 11028252
[TBL] [Abstract][Full Text] [Related]
9. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
Meibohm B; Derendorf H
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic-pharmacodynamic modeling of tolerance to the prolactin-secreting effect of chlorprothixene after different modes of drug administration.
Bagli M; Süverkrüp R; Quadflieg R; Höflich G; Kasper S; Möller HJ; Langer M; Barlage U; Rao ML
J Pharmacol Exp Ther; 1999 Nov; 291(2):547-54. PubMed ID: 10525070
[TBL] [Abstract][Full Text] [Related]
11. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine.
Raybon JJ; Boje KM
J Pharmacol Exp Ther; 2007 Mar; 320(3):1252-60. PubMed ID: 17138862
[TBL] [Abstract][Full Text] [Related]
13. Investigation of a cellular pharmacodynamic model exhibiting sharp response sensitivity and tolerance.
Siegel RA
J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):87-101. PubMed ID: 17160695
[TBL] [Abstract][Full Text] [Related]
14. Assessment of drug interactions relevant to pharmacodynamic indirect response models.
Earp J; Krzyzanski W; Chakraborty A; Zamacona MK; Jusko WJ
J Pharmacokinet Pharmacodyn; 2004 Oct; 31(5):345-80. PubMed ID: 15669772
[TBL] [Abstract][Full Text] [Related]
15. A semi-compartmental model describing the pharmacokinetic-pharmacodynamic relationship.
Ki S
Anesth Pain Med (Seoul); 2020 Jan; 15(1):1-7. PubMed ID: 33329783
[TBL] [Abstract][Full Text] [Related]
16. Role of dosage regimen in controlling indirect pharmacodynamic responses.
Gobburu JV; Jusko WJ
Adv Drug Deliv Rev; 2001 Mar; 46(1-3):45-57. PubMed ID: 11259832
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the dose-dependent time of peak effect in indirect response models.
Majumdar A
J Pharmacokinet Biopharm; 1998 Apr; 26(2):183-206. PubMed ID: 9795881
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic modeling in vivo.
Holford NH; Sheiner LB
Crit Rev Bioeng; 1981; 5(4):273-322. PubMed ID: 7023829
[TBL] [Abstract][Full Text] [Related]
19. Intermittent adaptation. A theory of drug tolerance, dependence and addiction.
Peper A
Pharmacopsychiatry; 2009 May; 42 Suppl 1():S129-43. PubMed ID: 19434551
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of morphine-induced neuronal nitric oxide production and antinociceptive tolerance development.
Heinzen EL; Pollack GM
Brain Res; 2004 Oct; 1023(2):175-84. PubMed ID: 15374743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
